Yaosu Technology Raises Nearly RMB200 Million in A+ Round

Yaosu Technology has completed an A+ round financing of nearly RMB200 million, with participation from Guofang Venture Capital, Qingsong Capital, GF Xinde, Oriental Fortune Capital, and Yunbai Capital, while existing shareholder Yayi Capital increased its investment, according to 36Kr. The company said the proceeds will be used to further build its “3D Bio Intelligence” platform, including upgrading vertical AI models and biological mechanism analysis capabilities, deploying a high-throughput automated experimental system, and continuing to accumulate multimodal biological data. It also plans to accelerate development of a Virtual Cell and a Biological World Model to support humanized data infrastructure for next-generation drug R&D.